ArticleBMC infectious diseases2026
Machine learning and meningitis prediction in pediatric invasive pneumococcal disease: a retrospective single-center study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the clinical characteristics of children with invasive pneumococcal disease (IPD) admitted to Kunming Children’s Hospital from 2020 to 2024, and to develop a risk stratification model for pneumococcal meningitis among children with confirmed or highly suspected IPD using multiple machine learning algorithms.
methodsA retrospective analysis was conducted on 65 pediatric patients with confirmed IPD, divided into a meningitis group (n = 37) and a non-meningitis group (n = 28). Clinical characteristics between the two groups were compared. Variable selection was performed using LASSO regression, and six machine learning models—Logistic Regression (LR), K-Nearest Neighbor (KNN), Naive Bayes (NB), Multilayer Perceptron (MLP), Random Forest (RF), and XGBoost—were constructed based on the selected features. Model performance was evaluated using AUC, F1 score, accuracy, sensitivity, and specificity, while Decision Curve Analysis (DCA) was employed to assess clinical utility.
resultsThe meningitis group exhibited stronger inflammatory responses and poorer outcomes (in-hospital death and treatment abandonment). The predominant serotypes were 19 F (25.8%), 19 A (20.9%), and 14 (17.7%). LASSO regression identified six key predictive variables: headache, vomiting, nuchal rigidity, disease course, C-reactive protein (CRP), and blood urea nitrogen (BUN). Among the machine learning models, Logistic Regression and MLP performed best, with AUC values of 0.942 and 0.947, respectively. DCA indicated the highest net clinical benefit for these two models. A nomogram based on the Logistic Regression model enabled individualized risk estimation within the IPD population.
conclusionPediatric pneumococcal meningitis remains associated with high disability rates and poor prognosis. The machine learning-based predictive model integrating clinical symptoms and laboratory indicators demonstrated a discriminative ability and may hold the potential to serve as a supportive tool for risk stratification among children with invasive pneumococcal disease. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.